These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 24792166)
21. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha. Frietze S; O'Geen H; Littlepage LE; Simion C; Sweeney CA; Farnham PJ; Krig SR BMC Genomics; 2014 Jun; 15(1):520. PubMed ID: 24962896 [TBL] [Abstract][Full Text] [Related]
22. 14-3-3τ drives estrogen receptor loss via ERα36 induction and GATA3 inhibition in breast cancer. Garan LAW; Xiao Y; Lin WC Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2209211119. PubMed ID: 36252018 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms of estrogen receptor-α upregulation in breast cancers. Miyoshi Y; Murase K; Saito M; Imamura M; Oh K Med Mol Morphol; 2010 Dec; 43(4):193-6. PubMed ID: 21267694 [TBL] [Abstract][Full Text] [Related]
24. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Eeckhoute J; Keeton EK; Lupien M; Krum SA; Carroll JS; Brown M Cancer Res; 2007 Jul; 67(13):6477-83. PubMed ID: 17616709 [TBL] [Abstract][Full Text] [Related]
25. Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice. Cornelissen LM; Henneman L; Drenth AP; Schut E; de Bruijn R; Klarenbeek S; Zwart W; Jonkers J J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):305-321. PubMed ID: 31729597 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling. Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753 [TBL] [Abstract][Full Text] [Related]
27. Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status. Garcia-Closas M; Troester MA; Qi Y; Langerød A; Yeager M; Lissowska J; Brinton L; Welch R; Peplonska B; Gerhard DS; Gram IT; Kristensen V; Børresen-Dale AL; Chanock S; Perou CM Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2269-75. PubMed ID: 18006915 [TBL] [Abstract][Full Text] [Related]
28. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth. Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686 [TBL] [Abstract][Full Text] [Related]
29. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer. Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377 [No Abstract] [Full Text] [Related]
30. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer. Cohen H; Ben-Hamo R; Gidoni M; Yitzhaki I; Kozol R; Zilberberg A; Efroni S Breast Cancer Res; 2014 Nov; 16(6):464. PubMed ID: 25410484 [TBL] [Abstract][Full Text] [Related]
31. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor. Ellison-Zelski SJ; Alarid ET Mol Cancer; 2010 Sep; 9():263. PubMed ID: 20920219 [TBL] [Abstract][Full Text] [Related]
32. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer. Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890 [TBL] [Abstract][Full Text] [Related]
34. The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer. Li W; Zhang Z; Liu X; Cheng X; Zhang Y; Han X; Zhang Y; Liu S; Yang J; Xu B; He L; Sun L; Liang J; Shang Y J Clin Invest; 2017 Sep; 127(9):3421-3440. PubMed ID: 28805661 [TBL] [Abstract][Full Text] [Related]
35. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. de Souza Rocha Simonini P; Breiling A; Gupta N; Malekpour M; Youns M; Omranipour R; Malekpour F; Volinia S; Croce CM; Najmabadi H; Diederichs S; Sahin O; Mayer D; Lyko F; Hoheisel JD; Riazalhosseini Y Cancer Res; 2010 Nov; 70(22):9175-84. PubMed ID: 20978187 [TBL] [Abstract][Full Text] [Related]
36. Hierarchical modularity in ERα transcriptional network is associated with distinct functions and implicates clinical outcomes. Tang B; Hsu HK; Hsu PY; Bonneville R; Chen SS; Huang TH; Jin VX Sci Rep; 2012; 2():875. PubMed ID: 23166858 [TBL] [Abstract][Full Text] [Related]
37. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity. Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763 [TBL] [Abstract][Full Text] [Related]
38. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator. Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501 [TBL] [Abstract][Full Text] [Related]
39. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Chou J; Lin JH; Brenot A; Kim JW; Provot S; Werb Z Nat Cell Biol; 2013 Feb; 15(2):201-13. PubMed ID: 23354167 [TBL] [Abstract][Full Text] [Related]
40. Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells. Dahlman-Wright K; Qiao Y; Jonsson P; Gustafsson JÅ; Williams C; Zhao C Carcinogenesis; 2012 Sep; 33(9):1684-91. PubMed ID: 22791811 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]